Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01408901 · ClinicalTrials.gov registry record · NA
Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD)
A NA study of Peripheral Arterial Disease, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 210
- Enrollment target
- 1
- Study location
NCT01408901: Completed NA study of Peripheral Arterial Disease, sponsored by Northwestern University.
NCT01408901 is a NA study of Peripheral Arterial Disease that has completed, run by Northwestern University. The registered enrollment target is 210 participants, below the 4,204-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01408901, a NA study of Peripheral Arterial Disease, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 210 participants
- Enrollment target
- 1
- Study location
Study Summary
The PROPEL study will test the hypothesis that GM-CSF combined with supervised treadmill exercise will significantly improve functional performance in patients with PAD more than GM-CSF alone or supervised treadmill exercise alone. In addition to identifying novel therapeutic options for patients with PAD, the current proposal is expected to identify mechanisms by which functional impairment is improved in patients with PAD.
Primary Outcome
In the six-minute walk, participants walk back and forth along a 100-ft hallway for six minutes after standardized instructions to complete as many laps as possible. Distance covered in six minutes is recorded.
Conditions Studied
Interventions
- BEHAVIORAL Supervised Treadmill Exercise Therapy
- OTHER Health education sessions (Control)
- DRUG granulocyte macrophage colony stimulating factor (GM-CSF)
Study Locations (1)
Illinois
- Northwestern University Feinberg School of Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2011-09 |
| Est. Completion | 2017-08-15 |
| Phase | NA |
What the finished NCT01408901 record still lists
NCT01408901 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, below the 4,204-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 3 interventions - of which Supervised Treadmill Exercise Therapy is the first listed.
NCT01408901 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT01408901 about?
NCT01408901 is a clinical study titled "Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD)". The PROPEL study will test the hypothesis that GM-CSF combined with supervised treadmill exercise will significantly improve functional performance in patients with PAD more than GM-CSF alone or supervised treadmill exercise alone. In addition to identifying novel therapeutic options for patients wi...
What is the current status of trial NCT01408901?
This trial is currently completed. It is a NA study. The enrollment target is 210 participants. The study started on 2011-09. Estimated completion is 2017-08-15.
What conditions does trial NCT01408901 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease.
What interventions are being tested in trial NCT01408901?
The interventions under investigation include: Supervised Treadmill Exercise Therapy (BEHAVIORAL), Health education sessions (Control) (OTHER), granulocyte macrophage colony stimulating factor (GM-CSF) (DRUG).
Who is sponsoring clinical trial NCT01408901?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01408901 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01408901's enrollment target sits among peer trials
210 23rd of 79 higher than 56 of 79 other Peripheral Arterial Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Arterial Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
-
Prehabilitation and Rehabilitation in PAD
RECRUITING · NA
-
Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
RECRUITING · NA
-
Assessment of the Utility of the Pantheris Small Vessel (SV) System
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia